SCHEMBL24845528

SCHEMBL24845528

COC(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCCCCN)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 3/20 0.70
MAP3K7 O43318 1/20 0.64
IRAK4 Q9NWZ3 9/20 0.61
EHMT2 Q96KQ7 1/20 0.60
KDM4E B2RXH2 3/20 0.60
MEN1 O00255 2/20 0.60
TSHR P16473 2/20 0.60
KMT2A Q03164 2/20 0.60
NPSR1 Q6W5P4 2/20 0.60
USP2 O75604 1/20 0.60
LMNA P02545 1/20 0.60
TP53 P04637 1/20 0.60
HSD17B10 Q99714 1/20 0.60
ITK Q08881 3/20 0.59
CLK2 P49760 2/20 0.58
CLK4 Q9HAZ1 2/20 0.58
CDK9 P50750 1/20 0.58
MST1R Q04912 1/20 0.58
DYRK3 O43781 1/20 0.55
ROCK2 O75116 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30163829 1.00 OPRK1 (0.70) OPRK1MAP3K7IRAK4EHMT2KDM4E
SCHEMBL24845489 1.00 OPRK1 (0.70) OPRK1MAP3K7IRAK4EHMT2KDM4E
SCHEMBL30163744 1.00 OPRK1 (0.70) OPRK1MAP3K7IRAK4EHMT2KDM4E
SCHEMBL30163651 0.95 OPRK1 (0.65) OPRK1MAP3K7IRAK4EHMT2KDM4E
SCHEMBL24845522 0.91 OPRK1 (0.71) OPRK1MAP3K7IRAK4EHMT2KDM4E
SCHEMBL24845486 0.91 OPRK1 (0.71) OPRK1MAP3K7IRAK4EHMT2KDM4E
SCHEMBL30163691 0.91 OPRK1 (0.71) OPRK1MAP3K7IRAK4EHMT2KDM4E
SCHEMBL30163668 0.91 OPRK1 (0.71) OPRK1MAP3K7IRAK4EHMT2KDM4E
SCHEMBL24845491 0.89 MAP3K7 (0.64) OPRK1MAP3K7IRAK4EHMT2KDM4E
SCHEMBL24845520 0.89 MAP3K7 (0.64) OPRK1MAP3K7IRAK4EHMT2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117561262-A Macrocyclic TAK1 inhibitors 阿奎利恩有限公司 2024-02-13 CN disclosed
WO-2023275199-A1 MACROCYCLIC TAK1 INHIBITORS AQILION AB (SE) 2023-01-05 WO disclosed